June 1 2016, 15.35 PM IST || Pocket News Alert
Patients no longer need to travel abroad for HeartMate 3™, the world’s first commercially approved fully magnetically-levitated left ventricular assist device (LVAD), proven to show high survival rates in advanced heart failure patients
The HeartMate 3™ implant surgery was performed in early May 2016 on Mr. Santoshkiran Kardiawar (name
↧